Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus-2 (TEMD-2 Study)
NCT ID: NCT06347445
Last Updated: 2024-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5707 participants
OBSERVATIONAL
2022-10-01
2023-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficiency of Telemedicine to Optimize Metabolic Control in Patients With Diabetes in Turkey
NCT04789798
The Effect of Education and Tele-Follow-Up Program on Diabetes Self-Management and Blood Glucose Regulation
NCT06963073
Motivational Interviewing and WhatsApp-Based Monitoring for Metabolic Control and Self-Efficacy in Adolescents With T1DM
NCT06635460
Effectiveness of Telehealth Program in Patients With Type 2 Diabetes
NCT05202470
Dual-Task Effects on Hand Functions in Type 2 Diabetes Mellitus
NCT05127291
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Common problems in diabetic patients, such as sleep disorders and sexual dysfunction, affect glycemia regulation in these patients.There is little data on the frequency of these diseases in diabetic patients in Türkiye.
In the TEMD-1 study conducted in 2017, the rates of diabetic patients achieving metabolic goals and the factors affecting these rates were revealed in Turkish patients with diabetes. The findings obtained in the current study will be compared with the findings in 2017, and in addition, the frequency of comorbidities such as sleep disorder, sexual dysfunction, and depression will be tried to be revealed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with diabetes mellitus
Patients with type 1 or type 2 diabetes who were under follow-up in the same center for at least a year.
There is no intervention.
There is no intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
There is no intervention.
There is no intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Upper than 18 years old
* To be under follow-up in the same center for at least one year.
Exclusion Criteria
* Younger than 18 years old
* History of psychiatric disorders interfering cognition or compliance
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gulhane School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
cem haymana
Associate Proffesor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alper Sonmez, Prof.
Role: PRINCIPAL_INVESTIGATOR
Ankara Guven Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gulhane School of Medicine Department of Endocrinology and Metabolism
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GSM012024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.